600079 Humanwell Healthcare(Group)Co.,Ltd.
Closed 12-23 15:00:00
19.45
+0.10
+0.52%
High19.46Low18.93Vol37.32M
Open19.26D1 Closing19.35Amplitude2.74%
Mkt Cap31.74BTradable Cap30.01BTotal Shares1.63B
T/O716.00MT/O Rate2.42%Tradable Shares1.54B
P/B1.68ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Humanwell Healthcare's Unit Gets Nod to Trial Pulmonary Drug
MT Newswires Live  ·  12-22 19:17
Humanwell Healthcare's Unit Gets Nod to Trial Pulmonary Drug
Humanwell Healthcare (600079.SH) Receives Clinical Trial Approval for HW252001 Tablets
Stock News  ·  12-19
Humanwell Healthcare (600079.SH) Receives Clinical Trial Approval for HW252001 Tablets
Humanwell Healthcare (600079) Receives Preliminary Administrative Penalty Notice, Affected Investors Eligible for Compensation Claims
Deep News  ·  12-19
Humanwell Healthcare (600079) Receives Preliminary Administrative Penalty Notice, Affected Investors Eligible for Compensation Claims
Heavy Penalty Imposed: Why Did ST Humanwell Healthcare Surge on First Trading Day?
Deep News  ·  12-17
Heavy Penalty Imposed: Why Did ST Humanwell Healthcare Surge on First Trading Day?
From Anesthesia Leader to ST Humanwell: A Life-or-Death Transformation After a Capital Game
Deep News  ·  12-17
From Anesthesia Leader to ST Humanwell: A Life-or-Death Transformation After a Capital Game
Humanwell Healthcare (600079) Receives Administrative Penalty Notice, Affected Investors Eligible for Compensation Claims
Deep News  ·  12-17
Humanwell Healthcare (600079) Receives Administrative Penalty Notice, Affected Investors Eligible for Compensation Claims
Humanwell Healthcare Faces Penalty for Financial Fraud, Compensation Claims Begin
Deep News  ·  12-15
Humanwell Healthcare Faces Penalty for Financial Fraud, Compensation Claims Begin
Breaking: Humanwell Healthcare to Face ST Designation
Deep News  ·  12-12
Breaking: Humanwell Healthcare to Face ST Designation
BRIEF-Trading In Humanwell Healthcare's Shares To Halt On December 15
Reuters  ·  12-12
BRIEF-Trading In Humanwell Healthcare's Shares To Halt On December 15
Humanwell Healthcare Says Trading in Its Shares to Halt on Dec 15 to Implement Other Risk Warning, Trading to Resume on Dec 16
THOMSON REUTERS  ·  12-12
Humanwell Healthcare Says Trading in Its Shares to Halt on Dec 15 to Implement Other Risk Warning, Trading to Resume on Dec 16
Humanwell Healthcare Gets German Approval for Midazolam Injection
MT Newswires Live  ·  12-12
Humanwell Healthcare Gets German Approval for Midazolam Injection
Humanwell Healthcare (600079.SH) Receives German Approval for Midazolam Injection
Stock News  ·  12-11
Humanwell Healthcare (600079.SH) Receives German Approval for Midazolam Injection
Slowdown in Services Activity Weigh on Chinese Stocks
MT Newswires Live  ·  12-03
Slowdown in Services Activity Weigh on Chinese Stocks
Humanwell Subsidiary Withdraws Application for Lower Limb Pain Drug; Shares Slide 3%
MT Newswires Live  ·  12-03
Humanwell Subsidiary Withdraws Application for Lower Limb Pain Drug; Shares Slide 3%
Humanwell Healthcare (600079.SH): Lisdexamfetamine Dimesylate Capsule Marketing Authorization Application Accepted
Stock News  ·  11-21
Humanwell Healthcare (600079.SH): Lisdexamfetamine Dimesylate Capsule Marketing Authorization Application Accepted
Humanwell Healthcare: Company Remains Focused on Core Pharmaceutical Business
Deep News  ·  11-14
Humanwell Healthcare: Company Remains Focused on Core Pharmaceutical Business
Humanwell Healthcare Unit Starts Phase Two Trial for Painkiller Drug
MT Newswires Live  ·  11-13
Humanwell Healthcare Unit Starts Phase Two Trial for Painkiller Drug
Humanwell Healthcare (600079.SH): HW231019 Tablets Enter Phase II Clinical Trial
Stock News  ·  11-12
Humanwell Healthcare (600079.SH): HW231019 Tablets Enter Phase II Clinical Trial
Humanwell Healthcare Gets Clinical Trial Nod for Pulmonary Hypertension Drug
MT Newswires Live  ·  11-07
Humanwell Healthcare Gets Clinical Trial Nod for Pulmonary Hypertension Drug
Humanwell Healthcare (600079.SH): HWH217 Tablets Approved for Clinical Trials in WHO Group 1 Pulmonary Arterial Hypertension
Stock News  ·  11-06
Humanwell Healthcare (600079.SH): HWH217 Tablets Approved for Clinical Trials in WHO Group 1 Pulmonary Arterial Hypertension

Introduction

Company Name.
人福医药集团股份公司
Industry:
医药制造业
Listing Date:
1997-06-06
Main Business:
　　人福医药集团股份公司的主营业务是药品的研发、生产和销售。公司的主要产品是枸橼酸舒芬太尼注射液、注射用盐酸瑞芬太尼、盐酸氢吗啡酮注射液、盐酸纳布啡注射液、盐酸阿芬太尼注射液、注射用苯磺酸瑞马唑仑、米非司酮制剂、祖卡木颗粒、复方木尼孜其颗粒、注射用尿激酶、硫酸新霉素原料药、黄体酮原料药。
Issue price:
5.22